Literature DB >> 7928110

The anti-inflammatory effect of opioids.

A Gavalas1, P Victoratos, M Yiangou, L Hadjipetrou-Kourounakis, E Rekka, P Kourounakis.   

Abstract

The anti-inflammatory activity of two novel opioids PM and PO as well as of pethidine was studied. The mouse paw edema, induced by various phlogistic agents, was significantly inhibited after the administration of opioids, fact that was independent of their antioxidant properties. The anti-inflammatory action of the above opioids was not reversed by naloxone. These results suggest that a variety of complex regulatory activities may be performed by opioid agonists via naloxone-sensitive or naloxone insensitive receptors on inflammatory cells, directly or indirectly by the inhibition of cytokines and mediators involved in inflammation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7928110     DOI: 10.3109/00207459408987244

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  5 in total

Review 1.  The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Jing Yu; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015-07-15       Impact factor: 2.581

2.  Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat.

Authors:  P Honoré; J Buritova; J M Besson
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway.

Authors:  Irina Vetter; Bruce D Wyse; Gregory R Monteith; Sarah J Roberts-Thomson; Peter J Cabot
Journal:  Mol Pain       Date:  2006-07-16       Impact factor: 3.395

4.  Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of Experimental Rheumatoid Arthritis.

Authors:  Susan Hua; Thilani H Dias; Debbie-Gai Pepperall; Yuan Yang
Journal:  Front Pharmacol       Date:  2017-08-02       Impact factor: 5.810

5.  Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions.

Authors:  Katerina S Iwaszkiewicz; Jennifer J Schneider; Susan Hua
Journal:  Front Pharmacol       Date:  2013-10-24       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.